SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.
The study will aim to prove oil-based seaweed product has the potential to be more effective than existing solutions Dr. Mallory Honan, Symbrosia's product and animal science lead, spoke about the ...
Despite headwinds, the U.S. life sciences industry continues to yield impressive results, leveraging technology for earlier ...
NEW YORK--(BUSINESS WIRE)--Builds Bio+, the premier life science membership organization that connects all segments of the life sciences ecosystem across major regional clusters, today announced the ...
Chiba, Japan, January 12, 2026—A team at Japan’s National Institutes for Quantum Science and Technology (QST) has published a field-defining Perspective that places the societal payoff of quantum ...
Atai Life Sciences announced positive results from Beckley Psytech's Phase 2a study of BPL-003, an adjunctive treatment for patients with treatment-resistant depression (TRD) who are already on ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Over the past 150 years, humanity has unleashed unimaginable energy by splitting ...
TMC is the world’s largest life science ecosystem, spanning across three distinct campuses - TMC Medical Campus, TMC Innovation Factory and TMC Helix Park, in the heart of Houston. Since 1945, TMC has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results